Vaccinex, Inc.
NASDAQ:VCNX
Overview | Financials
Company Name | Vaccinex, Inc. |
Symbol | VCNX |
Currency | USD |
Price | 1.31 |
Market Cap | 3,506,398 |
Dividend Yield | 0% |
52-week-range | 0.76 - 13.02 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Maurice Zauderer Ph.D. |
Website | https://www.vaccinex.com |
An error occurred while fetching data.
About Vaccinex, Inc.
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab, a humanized monoclonal antibody
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD